MediXall Group, Inc.
MDXL
$0.0035
$0.00026.06%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 94.50K | 65.50K | 71.50K | 77.90K | 20.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 94.50K | 65.50K | 71.50K | 77.90K | 20.20K |
| Cost of Revenue | 404.00K | 225.50K | 247.50K | 364.80K | 611.20K |
| Gross Profit | -309.50K | -159.90K | -175.90K | -286.90K | -590.90K |
| SG&A Expenses | 669.50K | 711.10K | 770.50K | 832.70K | 862.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -180.50K |
| Total Operating Expenses | 1.07M | 936.60K | 1.02M | 1.20M | 1.29M |
| Operating Income | -979.10K | -871.10K | -946.40K | -1.12M | -1.27M |
| Income Before Tax | -1.45M | -908.10K | -979.40K | -1.22M | -1.78M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.45M | -908.10K | -979.40K | -1.22M | -1.78M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.45M | -908.10K | -979.40K | -1.22M | -1.78M |
| EBIT | -979.10K | -871.10K | -946.40K | -1.12M | -1.27M |
| EBITDA | -951.90K | -869.80K | -945.10K | -1.12M | -1.24M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 130.52M | 130.49M | 127.45M | 122.19M | 118.96M |
| Average Diluted Shares Outstanding | 130.52M | 130.49M | 127.45M | 122.19M | 118.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
